Skip to main content
Download PDF

Siegesbeckia pubescens Makino inhibits Pam3CSK4-induced inflammation in RAW 264.7 macrophages through suppressing TLR1/TLR2-mediated NF-κB activation

Chinese Medicine volume 13, Article number: 37 (2018) Cite this article

Abstract

Background

Siegesbeckia pubescens Makino (SP) is one of the important plant origins for the anti-inflammatory Chinese herbal medicine of Siegesbeckiae Herba. The current investigations indicated that the anti-inflammatory effects of SP were associated with the toll-like receptors (TLRs)-mediated nuclear factor-κB (NF-κB) and the mitogen-activated protein kinase (MAPK) signaling pathways.

Methods

Raw 264.7 macrophages were pretreated with the 50% ethanol extract of SP (SPE, 50–200 µg/mL) and then co-treated with Pam3CSK4 (200 ng/mL) for another 12 h. The inhibitory effect of SPE on Pam3CSK4-stimulated NO release and post-inflammatory cytokines secretions were determined using Griess reagent and Elisa kits, respectively. The influence of SPE on NF-κB and MAPKs signaling relevant proteins was measured by Western blotting analysis, while the intracellular nitric oxide (NO) generation and NF-κB/p65 nuclear translocation were determined using Leica TCS SP8 laser scanning confocal microscope. Moreover, the effect of SPE on luciferase reporter gene in NF-κB-luc DNA transfected raw 264.7 cells was determined using the Dual-Glo luciferase assay system kit.

Results

SPE dose-dependently (50–200 µg/mL) attenuated Pam3CSK4-induced NO release, post-inflammatory cytokines (IL-6, TNF-α and MCP-1) secretions and intracellular NO generation in raw 264.7 cells. Biologically, SPE suppressed Pam3CSK4-induced expressions of cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), phosphorylation of NF-κB/p65 and IκBα, but did not significantly show effect on the proteins involved in MAPKs signaling (p38, ERK and JNK). The results were further confirmed by NF-κB-luc reporter gene assay and p65 nuclear translocation assay.

Conclusions

In conclusion, SPE ameliorated Pam3CSK4-induced inflammation in raw 264.7 cells through suppressing TLR 1/2-mediated NF-κB activation.

Background

Inflammation is an innate (non-specific) immune response and plays an important role in the physiological defense in response to various trauma or infection to the body [1]. An appropriate inflammatory response is necessary for the organism’s healing potential and facilitates tissue repair. However, an excessive or prolonged response might cause continuously damage to the body and induce many chronic diseases, organ dysfunction or organ failure [2, 3]. Therefore, an effective means of modulating systemic inflammation is beneficial for patients with chronic inflammatory autoimmune diseases, such as rheumatoid arthritis and diabetic nephropathy.

In the past decades, numerous studies indicated that transcription factors NF-κB target genes were involved in the occurrence and progress of various inflammations [4,5,6,7,8]. Activation of NF-κB stimulated macrophage recruitment and maturation, as well as the further production of pro-inflammatory cytokines and chemokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, monocyte chemoattractant protein (MCP)-1, and so on [9, 10]. Subsequently, the secreted inflammatory mediators further accelerated the degree of inflammation and the development of diseases [11]. On the other hand, being a family of transmembrane receptors closely related to the innate immune response [12], toll-like receptors (TLRs) (TLR1–TLR10 for human TLRs) present different functions on regulating inflammatory signaling and mediators based on their capacity to recognize the host derived agonists mostly released from the damaged cells or tissues during the progression of the diseases [13,14,15,16]. In triacyl lipoprotein-induced inflammations, the activation of NF-κB signaling pathways and production of various pro-inflammatory cytokines through TLR1/TLR2 (a heterodimer of TLR1 and TLR2) activation have been investigated and reported [17,18,19,20]. Therefore, targeting TLR1/TLR2 heterodimer-induced inflammation might be the potential therapeutic approach for such inflammatory diseases.

Siegesbeckia pubescens Makino (SP) is one of the plant origins of the traditional Chinese herbal medicine of Siegesbeckiae Herba, which has been widely used for various inflammatory diseases in China from the Tang dynasty. Currently, the chemical analysis indicated that SP mainly contained diterpenoids [21], sesquiterpenoids [22], flavonoids [23], glycosides [24] and some other constituents [25]. Moreover, the SP extracts or derived components were investigated to present various pharmacological activities such as anti-inflammatory [22, 26, 27], anti-allergic [28], and anti-cancer effects [29, 30]. The anti-inflammatory activity of SP was demonstrated to be related to its suppression on lipopolysaccharide (LPS)-induced nitric oxide (NO) [26] and inflammatory mediators [31] productions via NF-κB inactivation [32]. However, in our preliminary studies, the 50% ethanol extract of SP has been observed to have better activity against Pam3CSK4-(a specific TLR1/TLR2 agonist) than LPS-induced NO production in RAW 264.7 macrophages. In this study, the potential mechanisms of SP on Pam3CSK4-induced inflammation were further investigated and reported.

Methods

The Minimum Standards of Reporting Checklist contains details of the experimental design, and statistics, and resources used in this study (Additional file 1).

Chemical and reagents

Rutin, kirenol and darutoside (the purities of all standards were higher than 98% by HPLC analysis) were purchased from Chengdu Pufei De Biotech Co., Ltd. (Chengdu, China). Hoechst 33342, 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Griess reagent were purchased from Sigma Chemicals Ltd. (St. Louis, MO, USA). Milli-Q water was prepared using a Milli-Q system (Millipore, MA, USA).

Dulbecco’s modified eagle medium (DMEM) and fetal bovine serum (FBS) were purchased from Gibco (Carlsbad, CA, USA). Pam3CSK4 (N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-[R]-cysteinyl-[S]-seryl-[S]-lysyl-[S]-lysyl-[S]-lysyl-[S]-lysine·3HCl) was purchased from InvivoGen (San Diego, CA, USA). Enzyme-linked immunosorbent assay kits for IL-6, TNF-α, and MCP-1 were obtained from Neobioscience (Shenzhen, China). TurboFect transfection reagent was purchased from Thermo Fisher Scientific (Waltham, MA, USA). Antibodies were purchased from Santa Cruz Biotechnology (CA, USA) or Cell Signaling Tech (Danvers, MA, USA).

Preparation and characterization of SP extract (SPE)

The herbal material of SP was collected from Guiyang (Guizhou province, China) and authenticated by the corresponding author. The voucher specimens (No. SP-002) were deposited at the Institute of Chinese Medical Sciences, University of Macau, Macao, China.

The powdered SP (100 g) was extracted twice with 50% ethanol (1:10, w/v) for 1 h each under reflux. The combined extracts were filtered with filter paper after cooling and then concentrated under reduced pressure to remove the ethanol. The powdered SPE (yield: 27.3%) was obtained by lyophilizing the concentrated sample with a Virtis Freeze Dryer (The Virtis Company, New York, USA).

Quantification of rutin, kirenol and darutoside in SPE was performed using an Agilent HP1100 system (Hewlett Packard, Agilent, USA) coupled with an Elite Hypersil BDS C-18 analytical column (100 mm × 2.1 mm I.D., 3 μm) (Dalian, China) maintained at 25 °C. Elution was performed with a mobile phase of A (0.2% phosphoric acid in water) and B (0.2% phosphoric acid in ACN) under a gradient program by a linear increase from 10% B to 22% B in the first 30 min, and to 23% B in 10 min, then to 30% in 30 min. The flow rate was 0.35 mL/min, and the injection volume was 10 μL. The analytes were monitored at the UV wavelength of 215 nm. Prior to next injection, the column was washed with 100% B for 5 min and then equilibrated with the initial mobile phase for 10 min.

Cell culture

RAW 264.7 cells were obtained from the American Type Culture Collection (ATCC, Manassa, VA, USA). The cells were maintained in DMEM supplemented with 10% heat-inactivated FBS at 37 °C in humidified 5% CO2 atmosphere. The Minimum Standards of Reporting Checklist (Additional file 1) contains details of the experimental design, and statistics, and resources used in this study.

Cytotoxicity

The cytotoxicity of SPE on RAW 264.7 cells was detected using the MTT assay combined with lactose dehydrogenase (LDH) assay. In brief, the cells were seeded on a 96-well plate (1 × 104 cells/well) and allowed to adhere overnight. The cells were pretreated with SPE (25–200 μg/mL) for 4 h followed by co-treatment in the presence or absence of Pam3CSK4 (200 ng/mL) for 24 h. The cell proliferation was determined using the MTT assay as previous described [33]. The release of LDH in medium was determined using the LDH Cytotoxicity Detection Kit (ThermoFisher Scientific Inc., USA) according to the manufacturer’s instructions.

Nitric oxide (NO) production and inflammatory cytokines secretion assays

RAW 264.7 cells were seeded on a 24-well plate (1 × 105 cells/well) and allowed to adhere overnight. The cells were pretreatment with SPE (50, 100 and 200 μg/mL) or CU-CPT22 (4 µM, positive control) for 4 h and then co-treated with addition of Pam3CSK4 (200 ng/mL) for another 12 h. NO production was determined by measuring the accumulated nitrite in the culture medium with Griess reagent [33]. Cytokines (TNF-α, IL-6, and MCP-1) secretion in the supernatants of cultured cells was quantified using the enzyme-linked immunosorbent assay kits (Neobioscience, Shenzhen, China) following the manufacturer’s instructions.

Capture of intracellular NO generation

RAW 264.7 cells were cultured in glass bottom dish overnight and pretreated with SPE (50, 100 and 200 μg/mL) for 4 h. Subsequently, the cells were co-treated with Pam3CSK4 (200 ng/mL) for 12 h and then washed twice with ice-cold PBS. After incubated with 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate (DAF-FM, 5 μM in PBS) (ThermoFisher Scientific Inc., USA) for 30 min at room temperature, the cells were washed with PBS and then stained with 1 μg/mL Hoechst 33342 for 10 min. The images were obtained by a Leica TCS SP8 laser scanning confocal microscopy (Leica Microsystem, Wetzlar, Germany).

Western blotting analysis

RAW 264.7 cells were treated as described above. The harvested cells were washed thrice with ice-cold PBS and then extracted with RIPA buffer (Beyotime Biotechnology, Shanghai, China) containing protease inhibitor cocktails (ThermoFisher Scientific Inc., USA). The proteins (50 µg for each sample) were separated with SDS-PAGE (8%) and then transferred onto a PVDF membrane. The membranes were blocked with non-fat milk (5% in TBS containing 0.05% Tween-20, w/v) and incubated overnight at 4 °C with antibodies against iNOS, COX-2, p-IκBα, IκBα p-p65, p65 or GAPDH (1:1000). The membranes were then incubated with the corresponding secondary antibody (1:1000) at room temperature for 1 h. The signals were detected using ECL western blotting substrate (ThermoFisher Scientific Inc., USA) and ChemiDoc™ XRS+ system with Image Lab™ software (Bio-Rad Laboratories, Hercules, CA, USA).

Immunofluorescence analysis

RAW 264.7 cells were attached on confocal dish overnight. After pretreatment with SPE (200 μg/mL) for 2 h, the cells were co-treated with Pam3CSK4 (200 ng/mL) for another 4 h and then fixed with 4% Paraformaldehyde (PFA) for 10 min at room temperature. The cells were washed thrice with PBS, permeabilized with 0.05% Triton X-100 in PBS for 3 min, and followed by blocking with 3% bovine serum albumin (in PBS, w/v) for 1 h. Thereafter, the cells were incubated with antibody against p65 (1:100) overnight and reacted with Alexa Fluor 488-conjugated secondary antibody (1:1000) for 1 h. The nuclear of the cell was stained with Hoechst 33342. The images were captured with a Leica TCS SP8 laser scanning confocal microscopy.

Luciferase reporter gene assay

RAW 264.7 cells were transiently transfected with NF-κB-luc DNA for 48 h and refreshed with completed DMEM. The transfected cells were seeded in 6 plates overnight and pretreated with SPE (200 μg/mL) or CU-CPT22 (4 µM) for 2 h before Pam3CSK4 (200 ng/mL) stimulation for another 4 h. Luciferase activity was determined using a Dual-Glo luciferase assay system kit (Promega, Madison, Wisconsin, USA) following the manufacturer’s instructions.

Statistical analysis

Each experiment was performed in triplicate and was repeated for at least thrice. All results were presented as mean ± SD. Variance between two groups was evaluated by one-way ANOVA using the GraphPad Prism software (GraphPad Software, United States). The Newman–Keuls multiple comparison tests were performed for post hoc pairwise comparisons. P < 0.05 was considered statistically significant difference.

Results

Characterization of SP extract

The chromatograms of mixed standards and the SP extract were illustrated in Fig. 1. The contents of rutin, kirenol and darutoside in the extract were determined to be 0.27 ± 0.01, 1.81 ± 0.02 and 0.28 ± 0.03%, respectively.

Fig. 1
figure 1

HPLC chromatograms of (a) mixed standards (7.5 μg/mL of rutin, kirenol and darutoside) and (b) SPE (1 mg/mL). 1: rutin; 2: kirenol; 3: darutoside. The contents of rutin, kirenol and darutoside were determined to be 0.27 ± 0.01, 1.81 ± 0.02 and 0.28 ± 0.03%, respectively (n = 3)

Full size image

Cytotoxicity

The cytotoxicity of SPE on RAW 264.7 cells were determined using MTT and LDH assays. As illustrated in Fig. 2, SPE did not exert any observable toxicity on RAW 264.7 cells within the concentration ranged from 25 to 200 μg/mL while incubated with or without Pam3CSK4 (200 ng/mL) in 24 h. The concentrations of 50, 100 and 200 μg/mL were selected for SPE throughout the study.

Fig. 2
figure 2

Siegesbeckia pubescens Makino (SP) or SP with Pam3CSK4-stimulated did not significantly affect the cell viability and cytotoxicity (n = 3). RAW 264.7 cells were treated with SP with different concentrations for 24 h. a The cell viability was measured by MTT assay and c cell cytotoxicity was measured by LDH assay. RAW 264.7 cells were pretreated with SP for 4 h before Pam3CSK4 (200 ng/mL) stimulation for another 12 h. b The cell viability was measured by MTT assay and d cell cytotoxicity was measured by LDH assay

Full size image

SPE suppressed NO release and inflammatory cytokines secretions in Pam3CSK4-induced RAW 264.7 cells

Compared to the normal control cells, incubation with Pam3CSK4 for 12 h significantly induced the release of NO and secretion of inflammatory cytokines (IL-6, TNF-α, and MCP-1) in RAW 264.7 cells (Fig. 3). However, the stimulations were dose-dependently inhibited by SPE in the concentration ranged from 50 to 200 μg/mL. More than 50% of Pam3CSK4-stimulated NO release was observed to be decreased (> 50%) by SPE at the concentration higher than 100 μg/mL (Fig. 3a). The estimated IC50 of SPE on NO release was calculated to be 103.6 µg/mL. Moreover, SPE (200 μg/mL) significantly inhibited the Pam3CSK4-induced IL-6 (59.98%), TNF-α (42.38%), and MCP-1 (55.10%) (Fig. 3b–d). The inhibitory effects of SPE on Pam3CSK4-induced inflammation were comparable to those of the positive control of CU-CPT22 (4 µM).

Fig. 3
figure 3

Siegesbeckia pubescens Makino (SP) exhibited anti-inflammatory effects in Pam3CSK4-stimulated RAW 264.7 cells (n = 3). RAW 264.7 cells were pretreated with SP with different concentrations for 4 h before Pam3CSK4 (200 ng/mL) stimulation for another 12 h. a Nitric oxide (NO) was determined by Griess assay. TLR1/TLR2 antagonist: CU-CPT22 (CU) was selected as the positive control. We measured the levels of b IL-6, c TNF-α, and d MCP-1 by ELISA assay. *P < 0.05 vs. Pam3CSK4-induced, **P < 0.01 vs. Pam3CSK4-induced, ***P < 0.001 vs. Pam3CSK4-induced

Full size image

SPE attenuated Pam3CSK4-induced intracellular NO generation

The inhibitory effect of SPE on Pam3CSK4-induced intracellular NO generation was determined by confocal microscopy. As illustrated in Fig. 4, Pam3CSK4 significantly stimulated the intracellular NO generation in RAW 264.7 cells. This stimulation was attenuated by SPE in a dose-dependent manner (50–200 μg/mL).

Fig. 4
figure 4

RAW 264.7 cells were pretreated with Siegesbeckia pubescens Makino (SP) (n = 3) for 4 h before Pam3CSK4 (200 ng/mL) stimulation for another 12 h. NO was captured by Leica TCS SP8 laser scanning confocal microscope with 5 μM DAF-FM diacetate (4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate). CU-CPT22 (CU) is selected as the positive control

Full size image

SPE inhibited Pam3CSK4-induced the protein expressions of iNOS and COX-2

The protein expressions of iNOS and COX-2 in SPE-treated RAW 264.7 cells were analyzed by Western blotting assay and illustrated in Fig. 5. SPE was determined to dose-dependently inhibit the Pam3CSK4-induced iNOS and COX-2 protein expressions in RAW 264.7 cells. The related amounts of iNOS and COX-2 in SPE-treated cells were determined to be decreased by 61.42 and 74.65% respectively when compared to those in the Pam3CSK4-induced cells (Fig. 5b, c). Moreover, the phosphorylation of JNK1/2 and p38, but not ERK1/2, was observed to be increased under Pam3CSK4 stimulation; whilst, SPE did not present any influence on the phosphorylation of such proteins.

Fig. 5
figure 5

Effects of Siegesbeckia pubescens Makino (SP) on relevant pathways. RAW 264.7 cells were pretreated with SP (0, 50, 100 and 200 μg/mL) for 4 h and followed with Pam3CSK4 (200 ng/mL) addition for 12 h. CU-CPT22 (CU) is selected as the positive control. a Proteins was evaluated by Western blotting assay. b, c Quantification of iNOS and COX-2 protein was detected by densitometric analysis (n = 3). **P < 0.01 vs. Pam3CSK4-induced

Full size image

SPE inactivated Pam3CSK4-induced NF-κB signaling

Compared to the untreated cell group, SPE at high concentration (200 μg/mL) was observed to slightly increase the phosphorylation of IκBα but did not influence on the phosphorylation of NF-κB-p65 (Fig. 6a–c). However, under the inflammatory condition, SPE presented dose-dependent inhibition on Pam3CSK4-induced phosphorylation of IκBα and NF-κB-p65 in RAW 264.7 cells. The activated p-IκBα and p-NF-κB-p65 were decreased by 26.71 and 34.14%, respectively, while co-treated with SPE at 200 μg/mL for 12 h (Fig. 6a–c). The results suggested the involvement of NF-κB inactivation in Pam3CSK4-induced inflammation by SPE. Confirmed by luciferase reporter gene assay, SP significantly attenuated the NF-κB-driven luciferase activity in Pam3CSK4-stimulated RAW 264.7 cells (Fig. 6d). Furthermore, the Pam3CSK4-induced p65 nuclear translocation was also determined to be attenuated by SPE using the immunofluorescence staining assay (Fig. 7).

Fig. 6
figure 6

Effects of Siegesbeckia pubescens Makino (SP) on NF-κB pathways (n = 3). RAW 264.7 cells were pretreated with SP (0, 50, 100 and 200 μg/mL) for 2 h and followed with Pam3CSK4 (200 ng/mL) addition for 4 h. CU-CPT22 (CU) is selected as the positive control. a Proteins was evaluated by Western blotting assay. b, c Quantification was detected by densitometric analysis. d RAW 264.7 cells were transfected with NFκB-luc for 48 h. Cells were pretreated with SP 2 h before Pam3CSK4 (200 ng/mL) stimulation for another 4 h. Luciferase activity was determined by Dual-Glo Luciferase Assay. *P < 0.05 vs. Pam3CSK4-induced and **P < 0.01 vs. Pam3CSK4-induced

Full size image
Fig. 7
figure 7

RAW 264.7 cells were pretreated with 200 μg/mL of Siegesbeckia pubescens Makino (SP) (n = 3) for 2 h before Pam3CSK4 stimulation for another 4 h. NF-κB/p65 nuclear translocation was determined by immunofluorescence assay

Full size image

Discussion

In this work the anti-inflammatory effect and underlying mechanisms of SP on Pam3CSK4-induced inflammation in RAW 264.7 macrophages were investigated and reported.

TLRs have been demonstrated to play critical role in innate immune response in mammals against various infections. Up to date, 10 human TLRs (TLR1-TLR10) and 12 murine TLRs (TLR1-TLR9 and TLR11-TLR13) have been identified and demonstrated to react to various types of inflammations [13, 14]. Different to TLR4 (mainly response to LPS-induced inflammations), the TLR1–TLR2 heterodimer specifically responses to bacterial tri-acetylated lipopeptides or porins [34]. Activation of TLR1–TLR2 heterodimerization subsequently activates the NF-κB signaling [35] and MAPKs [17] pathways and up-regulates the inflammatory related proteins (such as iNOS and COX-2). Finally, the production of NO and secretion of inflammatory cytokines were increased. Using the specific TLR1–TLR2 heterodimerization stimulator of Pam3CSK4 [36], a synthetic tripalmitoylated lipopeptide with the similarity to the bacterial lipoproteins, the inflammatory responses are subsequently induced through activation on NF-κB signaling pathway.

Being a traditional anti-rheumatoid herbal medicine, SP was demonstrated to be beneficial to and has been applied for the management of various chronic inflammatory diseases [26,27,28]. The inactivation of TLR4-induced NF-κB signaling was identified to be involved in the biological mechanisms of SP on inhibiting the LPS-induced inflammations [32, 37]. However, our preliminary study, we observed that SPE presented more potency on suppressing Pam3CSK4-induced than LPS-induced NO release in RAW 264.7 macrophages. The results suggested the inhibition of SP on TLR1-TLR2 activation mediated inflammatory responses might be involved in its potential mechanisms on anti-inflammation. Further investigated in Pam3CSK4-stimulated macrophages, SPE improved the inflammatory responses of the cells by decreasing the NO release and cytokines (IL-6, TNF-α, and MCP-1) secretion into the culture medium. The biological mechanisms of such effect were identified to be associated with the suppressions of SPE on Pam3CSK4-stimulated NF-κB activation and up-regulation of the protein expressions of iNOS and COX-2. On the other hand, Pam3CSK4 stimulated inflammation by activating the MAPKs signaling, but SPE was determined to have no significant influences on the activated p38, ERK and JNK.

Previously, SP has been reported to contain multiple components. Diterpenoids, sesquiterpenoids and flavonoids have been determined to be the major components in SP [21,22,23,24]. Kirenol and darutoside, two ent-pimarane-type diterpenoids, were reported to be highly contained in SP [21, 38, 39]. Pharmacologically, the anti-inflammatory effects of SP were partially identified to be related to kirenol and darutoside [40]. Rutin, a widely distributed flavonoid in many plants, has been demonstrated to present various pharmacological activities such as anti-inflammation, anti-oxidant, anti-cancer as well as others [41]. In this study, the chemical compositions of SPE were analyzed using the HPLC method, the contents of the three representative components of kirenol (1.81 ± 0.02%), darutoside (0.28 ± 0.03%) and rutin (0.27 ± 0.01%) in SPE were quantified to be 2.36% in total. Further investigations on other chemical components in SPE as well as their relationship to TLR1-TLR2-activated inflammation are currently under progress in our research team.

Conclusions

In conclusion, the anti-inflammatory activity of SP on Pam3CSK4-stimulated RAW 264.7 macrophages was investigated and reported. The results demonstrated that the 50% ethanol extract of SP could effectively decrease Pam3CSK4-induced NO release and cytokines secretion in RAW 264.7 cells. The potential biological mechanisms of SP on anti-inflammation were associated with its inactivation on Pam3CSK4-stimulated NF-κB signaling.

Abbreviations

SP:

Siegesbeckia pubescens Makino

SPE:

50% ethanol extract of SP

NF-κB:

nuclear factor-κB

MAPK:

mitogen-activated protein kinase

TLR:

toll-like receptor

Pam3CSK4 :

N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-[R]-cysteinyl-[S]-seryl-[S]-lysyl-[S]-lysyl-[S]-lysyl-[S]-lysine·3HCl

NO:

nitric oxide

COX-2:

cyclooxygenase-2

iNOS:

inducible nitric oxide synthase

IL-6:

interleukin-6

IL-1β:

interleukin-1β

TNF-α:

tumor necrosis factor-α

MCP-1:

monocyte chemoattractant protein-1

LPS:

lipopolysaccharide

MTT:

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

DMEM:

Dulbecco’s modified eagle medium

FBS:

fetal bovine serum

LDH:

lactose dehydrogenase

DAF-FM:

4-amino-5methylamino-2′,7′-difluorofluorescein diacetate

References

  1. Hawiger J. Innate immunity and inflammation: a transcriptional paradigm. Immunol Res. 2001;23(2–3):99–109.

    Article  PubMed  CAS  Google Scholar 

  2. Sauaia A, Moore FA, Moore EE. Postinjury inflammation and organ dysfunction. Crit Care Clin. 2017;33(1):167–91.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kunnumakkara AB, Sailo BL, Banik K, Harsha C, Prasad S, Gupta SC, Bharti AC, Aggarwal BB. Chronic diseases, inflammation, and spices: how are they linked? J Transl Med. 2018;16(1):14.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107(1):7–11.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Shih RH, Wang CY, Yang CM. NF-kappaB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci. 2015;8:77.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Zhang H, Sun SC. NF-κB in inflammation and renal diseases. Cell Biosci. 2015;5:63.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Zhang Q, Lenardo MJ, Baltimore D. 30 years of NF-κB: a blossoming of relevance to human pathobiology. Cell. 2017;168(1–2):37–57.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Kulms D, Schwarz T. NF-kappaB and cytokines. Vitam Horm. 2006;74:283–300.

    Article  PubMed  CAS  Google Scholar 

  10. Hayden MS, Ghosh S. Regulation of NF-κB by TNF family cytokines. Semin Immunol. 2014;26(3):253–66.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Lai Y, Dong C. Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases. Int Immunol. 2016;28(4):181–8.

    Article  PubMed  CAS  Google Scholar 

  12. Jiménez-Dalmaroni MJ, Gerswhin ME, Adamopoulos IE. The critical role of toll-like receptors–from microbial recognition to autoimmunity: a comprehensive review. Autoimmun Rev. 2016;15(1):1–8.

    Article  PubMed  CAS  Google Scholar 

  13. Drexler SK, Foxwell BM. The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol. 2010;42(4):506–18.

    Article  PubMed  CAS  Google Scholar 

  14. Ospelt C, Gay S. TLRs and chronic inflammation. Int J Biochem Cell Biol. 2010;42(4):495–505.

    Article  PubMed  CAS  Google Scholar 

  15. Achek A, Yesudhas D, Choi S. Toll-like receptors: promising therapeutic targets for inflammatory diseases. Arch Pharm Res. 2016;39(8):1032–49.

    Article  PubMed  CAS  Google Scholar 

  16. Elshabrawy HA, Essani AE, Szekanecz Z, Fox DA, Shahrara S. TLRs, future potential therapeutic targets for RA. Autoimmun Rev. 2017;16(2):103–13.

    Article  PubMed  CAS  Google Scholar 

  17. Lee NY, Lee HY, Lee KH, Han SH, Park SJ. Vibrio vulnificus IlpA induces MAPK-mediated cytokine production via TLR1/2 activation in THP-1 cells, a human monocytic cell line. Mol Immunol. 2011;49(1–2):143–54.

    Article  PubMed  CAS  Google Scholar 

  18. Funderburg NT, Jadlowsky JK, Lederman MM, Feng Z, Weinberg A, Sieg SF. The toll-like receptor 1/2 agonists Pam(3) CSK(4) and human β-defensin-3 differentially induce interleukin-10 and nuclear factor-κB signalling patterns in human monocytes. Immunology. 2011;134(2):151–60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Khan J, Sharma PK, Mukhopadhaya A. Vibrio cholerae porin OmpU mediates M1-polarization of macrophages/monocytes via TLR1/TLR2 activation. Immunobiology. 2015;220(11):1199–209.

    Article  PubMed  CAS  Google Scholar 

  20. Broz P, Monack DM. Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol. 2013;13(8):551–65.

    Article  PubMed  CAS  Google Scholar 

  21. Huo L, Jiang Z, Li H, Wang M, Ye X, Ji B, Guo X. Simultaneous determination of seven major diterpenoids in Siegesbeckia pubescens Makino by high-performance liquid chromatography coupled with evaporative light scattering detection. J Sep Sci. 2012;35(19):2585–91.

    Article  PubMed  CAS  Google Scholar 

  22. Wang R, Liu YQ, Ha W, Shi YP, Hwang TL, Huang GJ, Wu TS, Lee KH. In vitro anti-inflammatory effects of diterpenoids and sesquiterpenoids from traditional Chinese medicine Siegesbeckia pubescens. Bioorg Med Chem Lett. 2014;24(16):3944–7.

    Article  PubMed  CAS  Google Scholar 

  23. Yao Y, Liang X, Sun X, Yin L, He H, Guo X, Jiang Z. Rapid extraction and analysis method for the simultaneous determination of 21 bioflavonoids in Siegesbeckia pubescens Makino. J Sep Sci. 2015;38(7):1130–6.

    Article  PubMed  CAS  Google Scholar 

  24. Wang J, Xie K, Duan H, Wang Y, Ma H, Fu H. Isolation and characterization of diterpene glycosides from Siegesbeckia pubescens. Bioorg Med Chem Lett. 2017;27(8):1815–9.

    Article  PubMed  CAS  Google Scholar 

  25. Tao HX, Xiong W, Zhao GD, Peng Y, Zhong ZF, Xu L, Duan R, Tsim KWK, Yu H, Wang YT. Discrimination of three Siegesbeckiae Herba species using UPLC-QTOF/MS-based metabolomics approach. Food Chem Toxicol. 2018. https://doi.org/10.1016/j.fct.2017.12.068.

    Article  Google Scholar 

  26. Lee M, Kim SH, Lee HK, Cho Y, Kang J, Sung SH. ent-kaurane and ent-pimarane diterpenes from Siegesbeckia pubescens inhibit lipopolysaccharide-induced nitric oxide production in BV2 microglia. Biol Pharm Bull. 2014;37(1):152–7.

    Article  PubMed  CAS  Google Scholar 

  27. Wang J, Cai Y, Wu Y. Antiinflammatory and analgesic activity of topical administration of Siegesbeckia pubescens. Pak J Pharm Sci. 2008;21(2):89–91.

    PubMed  Google Scholar 

  28. Kim HM. Effects of Siegesbeckia pubescens on immediate hypersensitivity reaction. Am J Chin Med. 1997;25(2):163–7.

    Article  PubMed  CAS  Google Scholar 

  29. Wang J, Duan H, Wang Y, Pan B, Gao C, Gai C, Wu Q, Fu H. ent-Strobane and ent-pimarane diterpenoids from Siegesbeckia pubescens. J Nat Prod. 2017;80(1):19–29.

    Article  PubMed  CAS  Google Scholar 

  30. Lv D, Guo KW, Xu C, Huang M, Zheng SJ, Ma XH, Pan LH, Wang Q, Yang XZ. Essential oil from Siegesbeckia pubescens induces apoptosis through the mitochondrial pathway in human HepG2 cells. J Huazhong Univ Sci Technol Med Sci. 2017;37(1):87–92.

    Article  PubMed  CAS  Google Scholar 

  31. Lee SG, Kim M, Kim CE, Kang J, Yoo H, Sung SH, Lee M. Quercetin 3,7-O-dimethyl ether from Siegesbeckia pubescens suppress the production of inflammatory mediators in lipopolysaccharide-induced macrophages and colon epithelial cells. Biosci Biotechnol Biochem. 2016;80(11):2080–6.

    Article  CAS  Google Scholar 

  32. Park HJ, Kim IT, Won JH, Jeong SH, Park EY, Nam JH, Choi J, Lee KT. Anti-inflammatory activities of ent-16alphaH,17-hydroxy-kauran-19-oic acid isolated from the roots of Siegesbeckia pubescens are due to the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB inactivation. Eur J Pharmacol. 2007;558(1–3):185–93.

    Article  PubMed  CAS  Google Scholar 

  33. Su T, Yu H, Kwan HY, Ma XQ, Cao HH, Cheng CY, Leung AK, Chan CL, Li WD, Cao H, Fong WF, Yu ZL. Comparisons of the chemical profiles, cytotoxicities and anti-inflammatory effects of raw and rice wine-processed Herba Siegesbeckiae. J Ethnopharmacol. 2014;156:365–9.

    Article  PubMed  CAS  Google Scholar 

  34. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, Lee H, Lee JO. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell. 2007;130:1071–82.

    Article  PubMed  CAS  Google Scholar 

  35. Cheng K, Gao M, Godfroy JI, Brown PN, Kastelowitz N, Yin H. Specific activation of the TLR1–TLR2 heterodimer by small-molecule agonists. Sci Adv. 2015;1(3):e1400139.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science. 1999;285(5428):736–9.

    Article  PubMed  CAS  Google Scholar 

  37. Li H, Kim JY, Hyeon J, Lee HJ, Ryu JH. In vitro antiinflammatory activity of a new sesquiterpene lactone isolated from Siegesbeckia glabrescens. Phytother Res. 2011;25(9):1323–7.

    PubMed  Google Scholar 

  38. Xu FQ, Liu JQ, Wang JT, Huang JP, Zhang J. Simultaneous determination of kirenol and darutoside in Siegesbeckiae Herba by high-performance liquid chromatography. Chin Tradit Pat Med. 2011;33(8):1444–6.

    CAS  Google Scholar 

  39. Ye XX, Song JX, Ji B, Jiang Z, Guo XJ. Simultaneous determination of five major constituents in Siegesbeckia pubescens Makino by HPLC-RID. J Shenyang Pharm Univ. 2014;31(1):36–40.

    CAS  Google Scholar 

  40. Lu Y, Xiao J, Wu ZW, Wang ZM, Hu J, Fu HZ, Chen YY, Qian RQ. Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance. Phytomedicine. 2012;19(10):882–9.

    Article  PubMed  CAS  Google Scholar 

  41. Chua LS. A review on plant-based rutin extraction methods and its pharmacological activities. J Ethnopharmacol. 2013;150(3):805–17.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors’ contributions

HY and YW organized, conceived, and supervised the study. WS and ZZ designed the study and conducted the experiments. KL, WX and WSC analyzed the data. AKWT edited and revised the manuscript. All authors read and approved the final manuscript.

Acknowledgements

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Funding

This study was supported by the National Natural Science Foundation of China (NSFC, No. 81470170), the Research Committee of the University of Macau (SRG2015-00060-ICMS-QRCM, MYRG2017-00178-ICMS, and CPG2014-00012-ICMS), the Guangzhou Science and Technology Innovation funding (EF007/ICMS-YH/2018/GSTIC), the Project funded by China Postdoctoral Science Foundation (No. 2017M622811), and the opening fund of the State Key Laboratory of Quality Research in Chinese Medicine of University of Macau (No. SKL-QRCM-2014-2016).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author information

Author notes

  1. Wei Sang and Zhangfeng Zhong contributed equally to this work

Authors and Affiliations

  1. Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Macao, China

    Wei Sang, Zhangfeng Zhong, Kegang Linghu, Wei Xiong, Wai San Cheang, Hua Yu & Yitao Wang

  2. HKBU Shenzhen Research Center, Shenzhen, Guangdong, China

    Hua Yu

  3. School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China

    Hua Yu

  4. Guangdong Key Laboratory for Research and Development of Natural Drugs, Guangdong Medical University, Zhanjiang, China

    Zhangfeng Zhong

  5. Academy for Advanced Interdisciplinary Studies, Southern University of Science and Technology, Shenzhen, Guangdong, China

    Anfernee Kai Wing Tse

  6. Institute of Chinese Medical Sciences, University of Macau, Room 8008, Building N22, Avenida da Universidade, Taipa, Macao SAR, China

    Hua Yu

  7. Institute of Chinese Medical Sciences, University of Macau, Room 1050, Building N22, Avenida da Universidade, Taipa, Macao SAR, China

    Yitao Wang

Authors
  1. Wei Sang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhangfeng Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kegang Linghu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wei Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anfernee Kai Wing Tse
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wai San Cheang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hua Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yitao Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Hua Yu or Yitao Wang.

Additional file

Additional file 1.

Minimum Standards of Reporting Checklist.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sang, W., Zhong, Z., Linghu, K. et al. Siegesbeckia pubescens Makino inhibits Pam3CSK4-induced inflammation in RAW 264.7 macrophages through suppressing TLR1/TLR2-mediated NF-κB activation. Chin Med 13, 37 (2018). https://doi.org/10.1186/s13020-018-0193-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13020-018-0193-x

Keywords

Chinese Medicine

ISSN: 1749-8546

Contact us